SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study

Clinical trial NCT02959606 · UNKNOWN

Trial details

NCT number: NCT02959606
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Peripheral Arterial Disease

Start date: 2016-12-01
Primary completion: 2019-01-01
Enrollment: 272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.